Loading clinical trials...
Loading clinical trials...
Gastroesophageal reflux disease (GERD) is a very common condition affecting up to 30% of adults. To date, therapy consists of powerful acid suppression with proton pump inhibitors (PPI). Nevertheless,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
KU Leuven
NCT04939051 · Barrett Esophagus, Esophageal Adenocarcinoma
NCT06071845 · Barrett Esophagus, Barretts Esophagus With Dysplasia, and more
NCT05753748 · Barretts Esophagus With Dysplasia, Barrett Esophagus, and more
NCT07063576 · GERD - PPI Non-responders
NCT05463796 · Cancer Risk, Cancer Predisposition Syndrome, and more
Catholic University Leuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions